Can anyone explain to us why Aegerion's stock price exceeds that of Isis Pharmaceutics by over $13.00 when the two drugs seem very close in similarity. Isis seems to be the one with the backers as well as cash.
Take a look at market capital and then report back. Hey how about a question for you? Can you tell me why AEGR keeps on telling everyone they are in the drug development business when they can't develop their own drugs? And can you tell me why they call themselves a biotech company when they are using a drug that is over 20 years old? And can you tell me how they have a pipeline when they have two drugs in the same class for the same indication that are both 20 years old? And can you tell me how a 23 patient study with no placebo can get through and how we are able to guage that as a say drug? And can you tell me why the CEO combs his hair the way he does? Thank you in advance. t